Sandu Pharmaceuticals Q3 Results

  • BSE: 524703
  • NSE: -
  • ISIN: INE751D01014
  • Sector: Biotechnology & Drugs
BSE
57.820.02 (0.03%)
Volume1.30 K
Updated: Tue 26 Nov, 2024 | 15:21:03
NSE
This stock is not traded on NSE
Today: 57.00
59.15
52-Wk: 54.00
85.00

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Sandu Pharmaceuticals Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 17.4316.61-%17.09-%
    Selling/ General/ Admin Expenses Total 2.532.55-%2.86-%
    Depreciation/ Amortization 0.140.13-%0.13-%
    Other Operating Expenses Total 5.764.94-%5.94-%
    Total Operating Expense 17.0615.91-%16.40-%
    Operating Income 0.370.69-%0.69-%
    Net Income Before Taxes 0.380.77-%0.70-%
    Net Income 0.210.55-%0.48-%
    Diluted Normalized EPS 0.210.57-%0.51-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts